October 29, 2021
SCOR has created "Vitae Breast Cancer", a relapse risk calculator
October 29, 2021
SCOR has created "Vitae Breast Cancer", a relapse risk calculator
Presentation
SCOR records a net income of EUR 339 million, demonstrating its shock-absorbing capacity, and launches a EUR 200 million share buy-back program
October 22, 2021
SCOR is revaluating the way we consider risk
October 21, 2021
Most of us will need long-term care at the end of our lives, yet it is one of the largest uninsured risks facing the elderly.
Presentations made during the Webinar
October 7, 2021
The 8th annual Global Consumer Study by ReMark, a SCOR Group company, sheds light on what consumers worldwide feel about health, AI, data privacy, and more.
October 1, 2021
Underwriting must accommodate the foundational changes entering the industry, like it or not. For some, this presents welcome opportunity; but for others, it represents the discomfort and threat of change.
October 1, 2021
The benefits of accelerated underwriting to applicants, direct companies and reinsurers are clear – faster, less intrusive, cost-effective underwriting with minimal mortality slippage, especially in programs that make
September 28, 2021
The eighth Prize was awarded to Axel Montagne of the University of Edinburgh
Pagination